Image

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Investigational Study of an Investigational Medication for Advanced Solid Tumors

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced solid tumors. It evaluates the safety and tolerability of an investigational medication called MT-4561.

The study focuses on understanding how MT-4561 affects the body and how the body processes the drug. It also looks at how effective the medication might be in treating the tumors.

  • Who can participate: Adults aged 18 and older who have tried at least one therapy without success and have no other standard treatment options may participate. Participants must have a life expectancy of at least 3 months and meet specific health criteria.
  • Study details: Participants will receive the investigational medication. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Head and Neck Squamous Cell Carcinoma (HNSCC)
    Non-small Cell Lung Cancer (NSCLC)
    Esophageal Cancer
    Gastric Cancer
    Biliary Tract Cancer
    Pancreatic Ductal Adenocarcinoma (PDAC)
    Breast Cancer
    Ovarian Cancer
    Cervical Cancer
    Endometrial Cancer
    Prostate Cancer
    Urothelial Carcinoma
    Neuroendocrine Tumor (NET)
    Neuroendocrine Carcinoma (NEC)
    Soft Tissue Sarcoma
    Nuclear Protein in Testis (NUT) Carcinoma

NCT06943521

Tanabe Pharma America, Inc.

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.